Cover Image

Online industry resources can help ensure continuity of care for patients on long-acting injectable antipsychotics while traveling or relocating

Saved in:

Bibliographic Details
Main Authors:	Brown Geoffrey W PharmD (Author), Bellnier Terrance J. RPh, MPA, FASCP (Author)
Format:	Book
Published:	American Association of Psychiatric Pharmacists, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024)

Assessment of oral overlap with antipsychotic long-acting injectables initiated in an inpatient setting
by: Tran Jennifer T. PharmD, et al.
Published: (2023)

Comment on "An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use"
by: Still Daniel PharmD, BCPP, et al.
Published: (2023)

Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit
by: Sarah Gamcsik, PharmD, et al.
Published: (2024)

Attitudes and perceptions about the use of long-acting injectable antipsychotics among behavioral health practitioners
by: Shaina Schwartz, PharmD, BCPP, et al.
Published: (2023)

Rural ambulatory care pharmacists providing in-clinic and home visit services improve adherence to long-acting injectable antipsychotics
by: Heng "Helen" Chang, PharmD, BCPS, et al.
Published: (2024)

An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
by: Amy M. VandenBerg, PharmD, BCPP
Published: (2022)

Stewardship applied to antipsychotics: Development of an antipsychotic stewardship program in inpatient settings for monitoring and optimizing outcomes
by: Gillian Gonzales, PharmD, et al.
Published: (2022)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023)

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
by: Danielle Dauchot, PharmD, et al.
Published: (2024)

Response to comment on the recently published article "An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use"
by: VandenBerg Amy M. PharmD, BCPP
Published: (2023)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
by: Christopher Evernden, BSc, BScPharm, ACPR, et al.
Published: (2021)

Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
by: Caballero Joshua PharmD, BCPP, FCCP, et al.
Published: (2023)

The place of long-acting injectable antipsychotics in the treatment of schizophrenia
by: John M. Kane, et al.
Published: (2023)

Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics
by: Shubhra Mace, et al.
Published: (2019)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
by: Francisco José Toja-Camba, et al.
Published: (2021)

The safety of lookalikes: a new THC beverage enhancer and a non-THC counterpart
by: Geoffrey W. Brown, et al.
Published: (2023)

Long-Acting Injectable Antipsychotics-A Review on Formulation and In Vitro Dissolution
by: Magdalena Markowicz-Piasecka, et al.
Published: (2023)

Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics
by: Ching-Hua Lin, et al.
Published: (2022)

Antipsychotic factors related to time to competency for forensic inpatients in a state psychiatric facility
by: Amber Lemons, PharmD, BCPP, et al.
Published: (2022)

Knowledge and attitude of Lebanese women about cosmetics: a cross-sectional survey
by: Bahia Chahine, RPh, PharmD, MSc, BCPS, et al.
Published: (2023)

Antipsychotic Drug Dispensations in Older Adults, Including Continuation After a Fall-Related Hospitalization: Identifying Adherence to Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria Using the Nova Scotia Seniors' Pharmacare Program and Canadian Institute for Health's Discharge Databases
by: Shanna C. Trenaman, MAHSR, ACPR, et al.
Published: (2018)

Training student pharmacists to administer long-acting injectable medications
by: Megan J. Ehret, PharmD, MS, BCPP, et al.
Published: (2024)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
by: David D. Kim, et al.
Published: (2021)

Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome
by: Beth M. DeJongh, PharmD, BCPP, BCPS
Published: (2021)

Offering a combined resident research training program and pharmacy student elective may help improve resident publication rates
by: Brown Geoffrey PharmD, et al.
Published: (2023)

Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility
by: Bailey B. Bass, PharmD, BCPS, et al.
Published: (2024)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021)

Attitudes and awareness of medical assistance while traveling abroad
by: Yi-Hsuan Lee, et al.
Published: (2018)

A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation
by: Natsuyo Ugumori, et al.
Published: (2021)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
by: Trevor A. Stump, PharmD, BCPP, et al.
Published: (2021)

Long-acting antipsychotic treatments: focus on women with schizophrenia
by: Sofia Brissos, et al.
Published: (2024)

Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022)

Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing
by: Danielle L. Stutzman, PharmD, BCPP
Published: (2021)

Ensuring continuous TB treatment across Asian borders
by: A. Ohkado, et al.
Published: (2024)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
by: Erica A. K. Davis, PharmD, BCPS, BCPP
Published: (2022)

Ensuring Equal Opportunities in an English-for-Specific-Purposes Course for Working-While-Studying Technical Students
by: Irina Sergeevna Oblova, et al.
Published: (2024)

Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
by: Francesco Bartoli, et al.
Published: (2023)

Pharmacist Administration of Long-Acting Injectable Antipsychotics to Community-Dwelling Patients: A Scoping Review
by: Andrea L. Murphy, et al.
Published: (2023)

Global Views on Climate Relocation and Social Justice Navigating Retreat
by: Ajibade, Idowu Jola
Published: (2022)